Back to top
more

Motion Acquisition (DCGO)

(Delayed Data from NSDQ)

$1.33 USD

1.33
568,763

-0.03 (-2.21%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $1.33 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Motion Acquisition (DCGO) delivered earnings and revenue surprises of -800% and 0.90%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Sera Prognostics (SERA) delivered earnings and revenue surprises of 16.67% and 62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

All You Need to Know About Motion Acquisition (DCGO) Rating Upgrade to Buy

by Zacks Equity Research

Motion Acquisition (DCGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

DocGo Inc. (DCGO) Q4 Earnings Beat Estimates

by Zacks Equity Research

Motion Acquisition (DCGO) delivered earnings and revenue surprises of 25% and 6.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DocGo (DCGO) Soars 7.9%: Is Further Upside Left in the Stock?

by Zacks Equity Research

DocGo (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

DocGo Inc. (DCGO) Tops Q3 Earnings Estimates

by Zacks Equity Research

Motion Acquisition (DCGO) delivered earnings and revenue surprises of 25% and 0.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DocGo Inc. (DCGO) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Motion Acquisition (DCGO) delivered earnings and revenue surprises of -14.29% and 0.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Establishment Labs (ESTA) delivered earnings and revenue surprises of -19.23% and 1.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sotera Health Company (SHC) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Sotera Health (SHC) delivered earnings and revenue surprises of 11.76% and 3.42%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DocGo Inc. (DCGO) Matches Q1 Earnings Estimates

by Zacks Equity Research

Motion Acquisition (DCGO) delivered earnings and revenue surprises of 0% and 3.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to Decline

by Zacks Equity Research

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

DocGo Inc. (DCGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Motion Acquisition (DCGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

DocGo Inc. (DCGO) Q4 Earnings Lag Estimates

by Zacks Equity Research

DocGo Inc. (DCGO) delivered earnings and revenue surprises of -53.85% and 1.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?

by Zacks Equity Research

DocGo Inc. (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks Equity Research

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

DocGo Inc. (DCGO) delivered earnings and revenue surprises of -166.67% and 4.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

by Zacks Equity Research

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Are Options Traders Betting on a Big Move in DocGo (DCGO) Stock?

by Zacks Equity Research

Investors need to pay close attention to DocGo (DCGO) stock based on the movements in the options market lately.

Zacks Equity Research

DocGo Inc. (DCGO) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

DocGo Inc. (DCGO) delivered earnings and revenue surprises of -200% and 1.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DocGo Inc. (DCGO) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

DocGo Inc. (DCGO) delivered earnings and revenue surprises of 120% and 4.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Motion Acquisition (DCGO) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how DocGo Inc. (DCGO) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.

Zacks Equity Research

Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Molina (MOH) and DocGo Inc. (DCGO) have performed compared to their sector so far this year.

Zacks Equity Research

Wall Street Analysts Think DocGo Inc. (DCGO) Could Surge 27%: Read This Before Placing a Bet

by Zacks Equity Research

The consensus price target hints at a 26.8% upside potential for DocGo Inc. (DCGO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Can DocGo Inc. (DCGO) Climb 30% to Reach the Level Wall Street Analysts Expect?

by Zacks Equity Research

The mean of analysts' price targets for DocGo Inc. (DCGO) points to a 30% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Can DocGo Inc. (DCGO) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

DocGo Inc. (DCGO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Why Earnings Season Could Be Great for DocGo (DCGO)

by Zacks Equity Research

DocGo (DCGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.